TrialAntimicrobial agents and chemotherapy2015

Bacterial resistance to leucyl-tRNA synthetase inhibitor GSK2251052 develops during treatment of complicated urinary tract infections.

Karen O'Dwyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.